← Back
Data updated: Jul 17, 2026
LANDELA PHARM
Generics Pharmaceuticals
LANDELA PHARM is a generic drug manufacturer with 3 FDA-approved products.
2002
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
LANDELA PHARM's Key Drugs
LANDELA PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
LANDELA PHARM's Recent FDA Approvals
New NDA/BLA approvals for LANDELA PHARM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
LANDELA PHARM's Therapeutic Areas
Disease areas where LANDELA PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
LANDELA PHARM Pipeline Snapshot
Active clinical trials for LANDELA PHARM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2002-01-30
- Latest
- 2011-07-11
- Applications
- 3